LAKE FOREST, Ill.--(BUSINESS WIRE)--Sirtex, a leading developer of targeted and innovative cancer therapies, is a participating sponsor at this year’s Carcinoid/Neuroendocrine Tumor (NET) Conference. The conference, which is hosted by the Washington & Oregon Chapters of the Pacific Northwest Carcinoid Cancer Support Group, will be held September 28-30 at the DoubleTree Hotel’s Lloyd Center in Portland, Ore. The mission of the conference is to present the latest information on neuroendocrine tumors to patients, caregivers and physicians.
